Zoetis (ZTS) Acquisitions (2015 - 2022)

Zoetis (ZTS) reported Acquisitions of $215.0 million for Q3 2022, down 88.59% quarter-over-quarter from $1.9 billion in Q3 2018.

Zoetis (ZTS) Acquisitions (2015 - 2022) Analysis & Trends

Zoetis (ZTS) has 5 years of Acquisitions data on file, last reported at $215.0 million in Q3 2022.

Acquisitions for Q3 2022 came in at $215.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $215.0 million (changed N/A YoY), and the FY2018 annual result was $1.9 billion, changed N/A from the prior year.
Acquisitions slipped to $215.0 million in Q3 2022 per ZTS's latest filing, from $1.9 billion in the prior quarter.
Over five years, Acquisitions peaked at $1.9 billion in Q3 2018 and troughed at $215.0 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	-
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	2.09 Bn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	137.87 Mn
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	-

Download Data